Hui Han: Influence Statistics

Hui Han

Hui Han

Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China | Center for Translational Medicine, Precision Medicine Institute, The First Affiliated Hospital, ...

Hui Han: Expert Impact

Concepts for which Hui Han has direct influence: Penile cancer , Radical cystectomy , Bladder cancer , Germ cell , Renal cell carcinoma , Ileal conduit , Cell carcinoma .

Hui Han: KOL impact

Concepts related to the work of other authors for which for which Hui Han has influence: Penile cancer , Cell carcinoma , Lymph node , Albumin ratio , Radical nephroureterectomy , Intravesical recurrence , Reactive protein .

KOL Resume for Hui Han

Year
2022

Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China

Center for Translational Medicine, Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen University

2021

Collaborative Innovation Center of Cancer Medicine, 510060, Guangzhou, Guangdong, P. R. China.

State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China

2020

Department of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China

2019

State Key Laboratory of Oncology in Southern China, Guangzhou, China

2018

Department of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China, .

Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, 510060, Guangzhou, China

2017

Department of Urology, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, 510060, Guangzhou, People’s Republic of China

2016

Department of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China

2015

1] Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, PR China [2] State Key Laboratory of Oncology in Southern China, Guangzhou, PR China [3] Collaborative Innovation Center of Cancer Medicine, Guangzhou, PR China.

State Key Laboratory of Oncology in Southern China Guangzhou China

2014

Department of Urology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, China

2013

Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Guangzhou Guangdong China

2012

Department of Urology, Sun Yat‐sun Uinversity Cancer Center, Guangzhou, China

2011

Department of Urology, Sun Yat-Sen University Cancer Center, Guangzhou 510060, Guangdong, PR China

2010

Department of Urology, Cancer Center, Sun Yat-Sen University and State Key Laboratory of Oncology in Southern China, Guangzhou, P. R. China

2009

State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, PR China

Prominent publications by Hui Han

KOL-Index: 11545 . BACKGROUND: The molecular mechanisms of the development and progression of bladder cancer are poorly understood. The objective of this study was to analyze the expression of Bmi-1 protein and its clinical significance in human bladder cancer. METHODS: We examined the expression of Bmi-1 mRNA and Bmi-1 protein by RT-PCR and Western blot, respectively in 14 paired bladder cancers and the ...
Known for Bladder Cancer | Expression Bmi1 | Prognostic Marker | Tumor Blotting
KOL-Index: 11433 . BACKGROUND: The molecular mechanisms involved in the development and progression of clear cell renal cell carcinomas (ccRCCs) are poorly understood. The objective of this study was to analyze the expression of dual-specificity phosphatase 9 (DUSP-9) and determine its clinical significance in human ccRCCs. METHODS: The expression of DUSP-9 mRNA was determined in 46 paired samples of ccRCCs ...
Known for Expression Dusp9 | Renal Cell | Tumorous Tissues | Poor Prognosis Ccrcc
KOL-Index: 10581 . ObjectiveTo evaluate factors in penile squamous cell carcinoma predictive of pelvic lymph node metastasis and survival.Materials and methodsData were collected and analyzed retrospectively in 146 patients with squamous cell carcinoma of penis who underwent bilateral inguinal lymph node dissection in our center between January 1998 and April 2011. Variables recorded included serum squamous ...
Known for Lymph Node | Squamous Cell | Risk Factors Presence | Aged Neoplasm
KOL-Index: 8916 . Background: Malnutrition and systemic inflammatory response are frequently associated with prognosis in patients with several types of cancer, including renal cell carcinoma (RCC). The study is aimed to investigate the ability of preoperative serum albumin to globulin ratio (AGR) to predict the long-term mortality of RCC patients. Methods: The study is a retrospective study of an ...
Known for Globulin Ratio | Preoperative Albumin | Prognostic Factor | Rcc Patients
KOL-Index: 8395 . BackgroundThe preoperative C-reactive protein/Albumin (CRP/Alb) ratio has been shown to be valuable in predicting the prognosis of patients with certain cancers. The aim of our study is to explore its prognostic value in patients with renal cell carcinoma (RCC).MethodsA retrospective study was performed in 570 RCC patients underwent radical or partial nephrectomy including 541 patients who ...
Known for Crp Alb | Reactive Protein | Renal Cell | Carcinoma Patients
KOL-Index: 8371 . OBJECTIVE: To investigate the value of removed lymph node (LN) count and LN density (LND) for predicting disease-specific survival (DSS) rate following radical lymphadenectomy in patients with penile cancer. METHODS: We retrieved data from 146 patients who were surgically treated between 2002 and 2012. receiver-operating characteristic curve analysis was used to calculate the optimal ...
Known for Penile Cancer | Lymph Node | Specific Survival | Multivariate Analysis
KOL-Index: 8241 . BACKGROUND: N7 -methylguanosine (m7 G) modification is one of the most common transfer RNA (tRNA) modifications in humans. The precise function and molecular mechanism of m7 G tRNA modification in hepatocellular carcinoma (HCC) remain poorly understood. METHODS: The prognostic value and expression level of m7 G tRNA methyltransferase complex components methyltransferase-like protein-1 ...
Known for Trna Modification | Mettl1 Wdr4 | Hepatocellular Carcinoma | N7 Methylguanosine
KOL-Index: 7985 . BACKGROUND: C14orf166 (chromosome 14 open reading frame 166) plays a crucial role in some tumors, but its role in bladder cancer hasn't been explored. METHOD: We determined C14orf166 expression in uroepithelial cell, bladder cancer cells, normal bladder tissues and bladder cancer tissues using quantitative RT-PCR and western blot, we then analyzed the correlation between C14orf166 ...
Known for Bladder Cancer | C14orf166 Expression | Cell Proliferation | Poor Survival
KOL-Index: 7457 . PURPOSE: Classic radical inguinal lymphadenectomy is associated with significant morbidity. Modified inguinal lymphadenectomy has been used to decrease the complication rate but it may compromise the oncological effect and depends on the use of intraoperative frozen sections, which may be inaccurate. We modified the technique of radical inguinal lymphadenectomy to decrease postoperative ...
Known for Penile Carcinoma | Inguinal Lymphadenectomy | Postoperative Complications | Modified Radical
KOL-Index: 7377 . Prediction of oncological outcomes facilitates individualized risk-adapted management for clinical stage I testicular nonseminomatous germ cell tumors (CS I NSGCTs). We investigated risk factors for relapse following orchidectomy, with particular focus on patients with active surveillance. Patients with CS I NSGCTs treated by retroperitoneal lymph node dissection (RPLND), chemotherapy, or ...
Known for Germ Cell | Clinical Stage | Relapse Patients | Testicular Neoplasms
KOL-Index: 7119 . OBJECTIVE: To investigate the association between body mass index and oncological outcomes in Chinese patients who had undergone radical nephroureterectomy for upper urinary tract urothelial carcinoma. METHODS: Between August 1998 and October 2009, 236 consecutive Chinese patients underwent radical nephroureterectomy for upper urinary tract urothelial carcinoma at Sun Yat-sen University ...
Known for Radical Nephroureterectomy | Urothelial Carcinoma | Underweight Patients | Urinary Tract
KOL-Index: 7065 . The research is to evaluate the age-specific differential effects of gender on outcomes in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU). Between August 1998 and October 2010, we retrospectively reviewed the data from 285 (67.7 %) men and 136 (32.3 %) women treated with RNU for UTUC at our two institutions. Kaplan–Meier survival ...
Known for Rnu Utuc | Tract Urothelial | Radical Nephroureterectomy | Specific Survival
KOL-Index: 6941 . OBJECTIVES: To introduce a modified technique for preventing complications related to stoma and ileoureteral anastomosis in patients undergoing ileal conduit diversion. METHODS: A urinary stoma was created intracorporeally and was pulled out to the abdominal wall through a retroperitoneal tunnel. The ileal conduit was fixed by nonabsorbable sutures that incorporated all abdominal wall ...
Known for Ileal Conduit | Modified Technique | Complications Stoma | Urinary Diversion
KOL-Index: 6581 . Despite its rare incidence worldwide, penile squamous cell carcinoma (PeSCC) still presents with significant morbidity and mortality due to the limited treatment options for advanced patients, especially those in developing countries. The program death-1 (PD-1)/PD-1 ligand (PD-L1) axis has been demonstrated to play an important role in tumor immune escape, and immunotherapies targeting ...
Known for L1 Expression | Tumor Cells | Squamous Cell | Developing Countries

Key People For Penile Cancer

Top KOLs in the world
#1
Simon Horenblas
penile cancer sentinel node cell carcinoma
#2
Suks S Minhas
penile cancer erectile dysfunction european association
#3
Philippe E Spiess
penile cancer radical cystectomy neoadjuvant chemotherapy
#4
Curtis Alvin Pettaway
prostate cancer african ancestry lymph node
#5
Antonio Leopoldo Cubilla
squamous cell human papillomavirus penile cancer
#6
Oliver Walter Hakenberg
penile cancer radical prostatectomy cell carcinoma

Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China | Center for Translational Medicine, Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen University | State Key Laboratory of Oncology in South China, Co